Press Releases and News

Sean Veale and Holly Lombardo

Meet Members of the Software Team

July 30, 2020

Sean Veale Holly Lombardo We sat down over a virtual cup of coffee in July 2020 to interview Sean Veale and Holly Lombardo from the software team at RedShiftBio. Editor: Morning, thank you both for joining us today. Can you tell us a bit about your role at RedShiftBio? SV: I am the Director of … “Meet Members of the Software Team”

RedShiftBio Appoints Topbiox as Exclusive Distributor in China

May 7, 2020

RedShift BioAnalytics, Inc. (RedShiftBio) announces its award winning AQS3pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in China, following the appointment of Beijing-based Topbiox as exclusive distributor.

Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics

April 16, 2020

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, today announced that the combination of PBI’s patented Pressure Cycling Technology (“PCT”) with RedShiftBio’s proprietary Microfluidic Modulation Spectroscopy (“MMS”) resulted in a powerful new platform for biotherapeutic drug development (“PCT-enhanced MMS”).

RedShiftBio Appoints Julien Bradley as new CEO

January 29, 2020

RedShift BioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for protein characterization used in biotherapeutic drug development, is pleased to announce the appointment of Julien Bradley as Chief Executive Officer.

The AQS³pro – A Hit For The Second Year Running at PEGS Europe

December 2, 2019

Lisbon Portugal hosted the European PEGS conference. This is the largest European event covering all aspects of protein and antibody engineering. Over 1300 attendees gathered to learn about the latest advances in protein and antibody engineering. This was the second year we showcased the next generation IR-based AQS3pro for secondary structure characterization. During this conference … “The AQS³pro – A Hit For The Second Year Running at PEGS Europe”

Accelerating Novel And Complex Modules Towards CMC Success

November 21, 2019

The 2020 Well Characterized Biologics and Biological Assays conference has just concluded. The agenda focused on practical advice for ensuring CMC success using characterization strategies. Most attendees we spoke with were interested in exploring alternative technologies to circular dichroism and FTIR for monitoring protein structure changes. We demonstrated the power of IR-based Microfluidic Modulation Spectroscopy … “Accelerating Novel And Complex Modules Towards CMC Success”